Range Capital Acquisition Corp. (RANGU) Stock Price & Analysis
Range Capital Acquisition Corp. (RANGU) closed at USD 11.32 on Wednesday, October 14, 2026, up 0.00% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 11.32; the Oct 14, 2026 session ranged USD 11.32–11.32 on volume of 3 shares. Market capitalization is —, with a 52-week range of USD 10.75–11.9 (NGM). Source: Nexqual, retrieved October 16, 2026 at 05:51 UTC.
Also available as compact Markdown for AI agents: nexqual.com/RANGU.md
Key facts (RANGU)
- Total return with dividends: 1Y +2.9% vs S&P 500 +18.1%; 5Y +13.2% vs S&P 500 +85.1%.
Total return (dividends reinvested) (RANGU)
| 1Y (from 2025-10-16) | 5Y (from 2024-12-16) | |
|---|---|---|
| Total return | +2.9% | +13.2% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | +2.9% | +7.0% |
| Volatility (annualized) | 12.5% | 11.3% |
| Max drawdown | -8.7% (May 2026→May 2026) | -8.7% (May 2026→May 2026) |
Key Statistics (as of October 16, 2026 at 05:51 UTC)
| Price | USD 11.32 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 11.32 |
| Open | USD 0 |
| Day Range | USD 11.32 – 11.32 |
| 52-Week Range | USD 10.75 – 11.9 |
| Volume | 3 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (RANGU)
Nexqual's technical model rates RANGU "NEUTRAL" based on 4 bullish and 3 bearish signals across 127 daily candles, as of October 16, 2026 at 05:51 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Above (USD 11.3) |
| MACD | 0.01 (positive) |
Earnings (RANGU)
Source: Nexqual, October 16, 2026 at 05:51 UTC.
Financials & Fundamentals (RANGU)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| Current Ratio | 0.23 |
| Total Cash | $1,862 |
| Total Debt | $172,000 |
Source: Nexqual, October 16, 2026 at 05:51 UTC.
Financial Health Score (RANGU)
Nexqual rates Range Capital Acquisition Corp.'s overall financial health "Weak" across five dimensions, as of October 16, 2026 at 05:51 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Gross margin 0%, operating 0% |
| Balance Sheet | Mixed — $2K cash, no debt |
| Cash Flow | Weak — Operating cash flow -$564K (TTM) |
| Efficiency | Mixed — No data |
Ownership (RANGU)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +1.07% |
| Float | 2.59M |
Source: Nexqual, October 16, 2026 at 05:51 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| VYLR | Vylor Inc. | USD 73.34 | ▼ 4.68% |
| DMII | Drugs Made In America Acquisiti | USD 10.19 | ▲ 0% |
| CCXI | Churchill Capital Corp XI | USD 11.35 | ▲ 1.7% |
| EVAC | EQV Ventures Acquisition Corp. | USD 10.3 | ▼ 0.1% |
| BCSS | Bain Capital GSS Investment Cor | USD 10.22 | ▼ 0.15% |
| CEPF | Cantor Equity Partners IV, Inc. | USD 10.26 | ▼ 0.24% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:51 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt